Christy J. Oliger - 07 Jun 2024 Form 3 Insider Report for Vera Therapeutics, Inc. (VERA)

Reporting relationship: Director
Issuer ticker: VERA
Reported as of: 07 Jun 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 11 Jun 2024, 16:15:00 UTC
Prior SEC filing: 30 May 2024
Next SEC filing: 02 Jan 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph R. Young, Attorney-in-Fact

Key filing fact

Christy J. Oliger filed Form 3 for Vera Therapeutics, Inc. (VERA) on 11 Jun 2024.

Key facts

This page summarizes Christy J. Oliger's Form 3 filing for Vera Therapeutics, Inc. (VERA).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Jun 2024, 16:15.

Change

Previous filing in this sequence was filed on 30 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VERA holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 2,987
Date: 07 Jun 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. The RSUs are fully vested as to service and shall settle on a date in 2025, as determined by the Issuer.